The advocacy group I AM ALS secured $313 million in federal funding for its campaign to accelerate research and expand access to treatment.

ALS Association yearly report cards show no U.S. state earned the highest score for policies supporting patients; several had ...

ALS ONE will join the ALS Network to expand ALS research efforts, improve patient services, and strengthen nationwide ...

A study is exploring why athletes, first responders, and other high performers face an increased risk of developing ALS.

A bipartisan team of U.S. lawmakers has reintroduced the ALS Better Care Act, aimed at improving access to quality medical ...

Half of the planned 200 ALS patients have joined Medicinova’s expanded access program evaluating the experimental drug MN-166 ...

An inflammatory sugar molecule produced by certain gut bacteria may play a key role in driving ALS, a study found.

In carrying on her late husband's tradition of feeding wildlife, columnist Juliet Taylor realizes that her actions are a way of honoring him.

A dream in the night takes columnist Kristin Neva back to when she and her husband, Todd, were free from ALS hanging over their heads.

Origami is collaborating with Ipsen to develop molecules designed to remove or correct abnormal proteins in neurodegenerative diseases.

The rollator industry is overdue for a transformation, says columnist Dagmar Munn, a longtime user of the device who is living with ALS.

Coya Therapeutics raised $11.1 million to support manufacturing scale-up for its experimental ALS therapy, COYA 302.